How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
Phase 1 Imaging Study of 68Ga-R10602-101 in Hormone Receptor-Positive Breast Cancer
Description:
A phase 1 imaging study of 68Ga-R10602 in hormone-receptor positive breast cancer.
Sponsor:
Radionetics Oncology
Contacts:
Yael Cohen-Arazir10602-101@radionetics.com
858-373-7793
Kristrun Stardalr10602-101@radionetics.com
949-887-9494
Government Study Link:
NCT06745804 - Click here to see study onClinicalTrials.gov
68Ga-R10602
Isotope(s):
Target(s):
- G protein-coupled receptors (GPCRs)
